ArticleNeuro-oncology advances

Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data.

Scott Raskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.